Home › Funds › Samsara BioCapital, LLC › AQST

Samsara BioCapital, LLC position in AQST

AQUESTIVE THERAPEUTICS INC COM · Health Care

Samsara BioCapital, LLC reported holding 2,500,000 shares of AQST (AQUESTIVE THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 0.85% of its reported portfolio and ranking #14 among its reported holdings. Samsara BioCapital, LLC has disclosed AQST holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)2.50M sh
Reported value held$10.40M
Portfolio Weight0.85%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's AQST position evolved

Samsara BioCapital, LLC first disclosed a stake in AQST in Q3 2025 at 2,500,000 shares (US$14.0M). The position peaked in Q4 2025 at 2,500,000 shares, worth US$16.1M. Across 4 filings, Samsara BioCapital, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,500,000 shares valued at US$10.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 2.50M $13.97M New
Q4 2025 2.50M $16.15M Hold
Q1 2026 2.50M $10.38M Hold
Q2 2026 2.50M $10.40M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AQST and 13F data

AQST (AQUESTIVE THERAPEUTICS INC COM) is a Health Care company. 40 other funds we track also report a position in AQST — the largest reported positions include Bratton Capital Management, L.P. (US$40.8M), Sio Capital Management, LLC (US$6.2M), Propel Bio Management, LLC (US$6.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AQST

All AQST fund holders →

FAQ

How long has Samsara BioCapital, LLC held AQST?

Samsara BioCapital, LLC has disclosed AQST holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Samsara BioCapital, LLC's current position in AQST?

As of Q2 2026, Samsara BioCapital, LLC holds 2.50M shares of AQST (AQUESTIVE THERAPEUTICS INC COM), valued at $10.40M, representing 0.85% of its reported portfolio and ranking #14.

Has Samsara BioCapital, LLC been buying or selling AQST?

In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC held unchanged its position in AQST. The position peaked in Q4 2025 at 2.50M shares.

Which other funds hold AQST?

Other major institutional holders of AQST include Bratton Capital Management, L.P., Sio Capital Management, LLC, Propel Bio Management, LLC, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.